Tetraphase Pharmaceuticals, Inc. (TTPH)

1.06
NASDAQ
Prev Close 1.09
Day Low/High 1.02 / 1.09
52 Wk Low/High 1.01 / 4.49
Exchange NASDAQ
Shares Outstanding 53.74B
Market Cap 58.58M
Div & Yield N.A. (N.A)

Latest News

Biotech Breakout

Given my risk-averse profile, I made the unusual move last week of buying a basket of biotech stocks. And yesterday, I noted that Biotech Could Be Close to a 'Double Bottom': "I recently created a basket of a dozen speculative and conservative biote...

Buying Biotechs

The iShares Nasdaq Biotechnology ETF (IBB) has tumbled from nearly $400 a share early last summer to around $240 at last check, so I'm taking advantage of today's market schmeissing to purchase a small position in a biotech (biowreck?). I'm buying a...

Market Wrap: Giving It All Back and Then Some

U.S. stock finished in the red across the board after early gains.

Tetraphase downgraded at Cantor

Tetraphase downgraded at Wedbush

Playing Biotechs with the House's Money

Playing Biotechs with the House's Money

Here's how to lock in gains on risky small-cap biotechnology stocks.

Develop Biotech 'Buy-Sell' Strategy

Develop Biotech 'Buy-Sell' Strategy

When to take profits is a tricky but important decision.

Two Small-Cap Biotechs To Consider

Two Small-Cap Biotechs To Consider

Fibrocell Science and Prothena have several 'shots on goal.'

Medical IPOs - Are They Healthy?

Medical IPOs - Are They Healthy?

IPO Desktop President Francis Gaskins and TheStreet's Debra Borchardt look at the Enanta Pharmaceuticals and Tetraphase Pharmaceuticals offerings.